SilcsBio Patent

SilcsBio has exclusive rights to use U.S. and foreign patents pending by the University of Maryland, Baltimore. Patents include: U.S. Patent Application 13/265,568, titled “Method for binding site identification by molecular dynamics simulation (SILCS: Site Identification by Ligand Competitive Saturation),” published as US 2012/0053067.

SILCS Drug Design Method

SILCS: Site Identification by Ligand Competitive Saturation is a ligand or drug design program that calculates the probability that general classes or specific R-groups will bind to a target molecule. This allows a medicinal chemist to design molecules that have a higher probability of binding the target protein. This method was developed by Dr. Alex[…]